Linzagolix

Linzagolix Structure
CAS No.
935283-04-8
Chemical Name:
Linzagolix
Synonyms
OBE2109;OBE 2109;OBE-2109;Linzagolix;Linzagolix CAS;Zavegepant Impurity 55;3-(5-((2,3-difluoro-6-methoxybenzyl)oxy)-2-fluoro-4-methoxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylic acid;3-[5-[(2,3-Difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl]-1,2,3,4-tetrahydro-2,4-dioxothieno[3,4-d]pyrimidine-5-carboxylic acid;Thieno[3,4-d]pyrimidine-5-carboxylic acid, 3-[5-[(2,3-difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl]-1,2,3,4-tetrahydro-2,4-dioxo-;KLH 2109,endometriosis,KLH-2109,GnRH Receptor,Gonadotropin releasing hormone receptor,inhibit,uterine fibroids,KLH2109,Linzagolix,GNRHR,adenomyosis,OBE 2109,Inhibitor,OBE-2109,OBE2109
CBNumber:
CB54844986
Molecular Formula:
C22H15F3N2O7S
Molecular Weight:
508.42
MOL File:
935283-04-8.mol
Modify Date:
2024/7/2 8:55:11

Linzagolix Properties

storage temp. Store at -20°C
solubility DMSO : 125 mg/mL (245.86 mM; Need ultrasonic)
form Solid
color White to light brown

Linzagolix Chemical Properties,Uses,Production

Linzagolix Suppliers

Linzagolix Thieno[3,4-d]pyrimidine-5-carboxylic acid, 3-[5-[(2,3-difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl]-1,2,3,4-tetrahydro-2,4-dioxo- OBE 2109 OBE2109 OBE-2109 KLH 2109,endometriosis,KLH-2109,GnRH Receptor,Gonadotropin releasing hormone receptor,inhibit,uterine fibroids,KLH2109,Linzagolix,GNRHR,adenomyosis,OBE 2109,Inhibitor,OBE-2109,OBE2109 3-[5-[(2,3-Difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl]-1,2,3,4-tetrahydro-2,4-dioxothieno[3,4-d]pyrimidine-5-carboxylic acid 3-(5-((2,3-difluoro-6-methoxybenzyl)oxy)-2-fluoro-4-methoxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylic acid Linzagolix CAS Zavegepant Impurity 55 935283-04-8 C22H15F3N2O7S